A Digital Publication for the Practicing Medical Specialist, Industry Executive & Investor

No Carolina / New York

Proximie Partners with Jhpiego in New Initiative to Improve Obstetric Surgical Care

Globally, approximately 810 women die every day from preventable causes related to pregnancy and childbirth. In addition, around 6700 newborns die every day, amounting to 47% of all under-5 deaths. Moreover, about 2 million babies are stillborn every year, with over 40% occurring during labor

Proximie has teamed up with Jhpiego, a Johns Hopkins University affiliate, on a safe surgery project in Kenya to layer in their unique software that allows physicians anywhere in the world to virtually ‘scrub-in’ and mentor colleagues in real time.

Proximie has offered its technology to Jhpiego, a global health non-profit working in 40-plus countries, to improve obstetric surgical care for women by expanding and enhancing the learning and mentorship in Jhpiego’s Obstetric Safe Surgery project now underway in five hospitals in Makueni County. The goal of the 22-month project is to support the government of Kenya’s commitment to reduce maternal and newborn deaths and obstetric-related injuries by improving the quality of caesarean sections. Seventy-one percent of facility-based maternal deaths in Kenya are associated with caesarean sections, and 9 out of 10 maternal deaths are linked to a lack of quality standardized care.

Funded by Johnson & Johnson, the Jhpiego-led project is grounded in a health-systems approach, leveraging local expertise to build networks of care to deliver safe and timely surgical obstetric care.  The Proximie platform offers the prospect of enhanced and expanded learning by obstetric surgical teams.

Supporting the design and evaluation of the enhanced OSS project is Ariadne Labs, a joint center for health systems innovation at Brigham and Women’s Hospital, and the Harvard T.H. Chan School of Public Health.

Dr. Doris Mbithi, Medical Superintendent of the Mother and Child Hospital in Makueni County and a partner on the OSS project, said the Jhpiego-Proximie alliance will help surgeons perfect their skills and address issues that arise.

“Sometimes things happen in the (operating) theatre and not all team members remember the process,” she said. “With the recordings, we can identify gaps and rectify. I am also happy that at night, I have the possibility to support remotely, either at my hospital or to help keep a potential referral at the sub county hospital by consulting remotely.”

Dr. John Varallo, Global Director Safe Surgery at Jhpiego, said the partnership can increase the impact realized thus far: “By offering real-time, remote surgical consultation, this project has the true potential of being a game-changer in improving the safety and quality of surgical care in Kenya, and in other countries where Jhpiego works. Collaborating with innovative thought leaders at Proximie and Ariadne Labs, and continuing to work in close partnership with the government of Kenya and the surgical teams on the ground, our true champions of the Obstetric Safe Surgery work, we have the opportunity to amplify the progress made in surgical safety and quality to date.”

Dr. Nadine Hachach-Haram, CEO of Proximie, said she founded Proximie “on the ethos that shared knowledge leads to accelerated learning and better patient care,” and the Obstetric Safe Surgery project embodies that.

“Our work with the local surgical teams on the ground in Kenya, and with Jhpiego, and Ariadne Labs, is going to help democratize access to important caesarean section surgical techniques and knowledge that would otherwise be siloed due to geography or time,” Hachach-Haram said. “Proximie is going to be harnessed pre, intra and postoperatively in order to ensure women and their babies have access to high-quality care, at a critical time. I have always believed that collaboration is the cornerstone of driving meaningful change in healthcare and the Obstetric Safe Surgery project will not just help to reduce maternal and neonatal mortality, but hopefully provide a blueprint for others to follow.”

A leader in healthcare innovation and implementation, Ariadne Labs has experience in designing and building in-country capacity and expertise to implement digital innovations which will be leveraged to inform critical discussions on sustainable digital health throughout Kenya, and beyond.

“We’re pleased to collaborate with Proximie and Jhpiego to leverage our experience in public health, frontline clinical care, and human-centered design to improve the quality of surgical care that women and their newborns receive as well as enhance the clinician experience,” said Katherine Semrau, PhD, MPH, Principal Investigator and Director of Ariadne Labs’ BetterBirth program. “Our aim at Ariadne Labs is to reduce suffering and save lives for people everywhere — whether in Boston, Nairobi, or Lucknow — by developing scalable, systems-level solutions. We look forward to supporting the measurement and evaluation of this work, to ultimately improve the interventions and their implementation.”

 

 

Medical Device News Magazinehttps://infomeddnews.com
Medical Device News Magazine provides breaking medical device / biotechnology news. Our subscribers include medical specialists, device industry executives, investors, and other allied health professionals, as well as patients who are interested in researching various medical devices. We hope you find value in our easy-to-read publication and its overall objectives! Medical Device News Magazine is a division of PTM Healthcare Marketing, Inc. Pauline T. Mayer is the managing editor.

More News!

Dr. Sachita Shah, Sr. Director, Global Health, Butterfly Network, "Butterfly is proud to continue improving maternal health equity through Phase Two of the largest-scale handheld ultrasound distribution and training ever conducted in Sub-Saharan Africa. South Africa is an emerging market that continues to have disproportionately high rates of maternal mortality and stillbirth. Patients need easier access to antenatal imaging, and clinicians need better capabilities for screening high-risk conditions that lead to disproportionately worse pregnancy outcomes in rural areas in the public sector. Together with CHAI and GUSI, we can tackle this by making ultrasound much more accessible, so high-risk conditions can be identified earlier in care, which is known to improve outcomes.”
The clinical Study will enroll up to 97 patients at up to 12 European investigational sites. Completion of the study is expected this year, and results will support CE mark and pre-market approval submissions reports Vivasure Medical.
Dr. Michael Newman, Indaptus’ Founder, Chief Scientific Officer, and lead author, commented, “The new data are consistent with our preclinical animal tumor model studies and provide evidence for our hypothesis that patented Decoy bacteria can activate a wide range of innate and adaptive human immune cells involved in fighting tumors.  This aligns with what we’ve observed in our ongoing Phase 1 clinical trial of Decoy20 – broad immune activation, as evidenced by transiently increased levels of many key cytokines and chemokines following single dose administration. These findings bolster our confidence in Decoy20's potential as a multifaceted immunotherapy.”
To further understand the impact of platforms like TikTok on nutrition trends, MyFitnessPal partnered with Dublin City University on a research and experimental study that examined diet and nutrition content on TikTok. The study analyzed over 67,000 videos using Artificial Intelligence to compare them against public health and nutrition guidelines
Leveraging the power of Apple Vision Pro to seamlessly blend digital content with the physical world Osso Health brings the operating experience to life via detailed, clinically accurate workflows of common procedures.

By using this website you agree to accept Medical Device News Magazine Privacy Policy